- Home
- OTTR vs CPRX Comparison
OTTR vs CPRX Comparison
Compare OTTR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTTR
- CPRX
- Stock Information
- Founded
- OTTR 1907
- CPRX 2002
- Country
- OTTR United States
- CPRX United States
- Employees
- OTTR N/A
- CPRX N/A
- Industry
- OTTR Electric Utilities: Central
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- OTTR Utilities
- CPRX Health Care
- Exchange
- OTTR Nasdaq
- CPRX Nasdaq
- Market Cap
- OTTR 3.1B
- CPRX 2.5B
- IPO Year
- OTTR N/A
- CPRX 2006
- Fundamental
- Price
- OTTR $77.50
- CPRX $23.96
- Analyst Decision
- OTTR
- CPRX Strong Buy
- Analyst Count
- OTTR 0
- CPRX 7
- Target Price
- OTTR N/A
- CPRX $32.86
- AVG Volume (30 Days)
- OTTR 214.9K
- CPRX 1.4M
- Earning Date
- OTTR 02-17-2025
- CPRX 02-26-2025
- Dividend Yield
- OTTR 2.41%
- CPRX N/A
- EPS Growth
- OTTR 9.18
- CPRX 114.68
- EPS
- OTTR 7.24
- CPRX 1.18
- Revenue
- OTTR $1,341,750,000.00
- CPRX $460,482,000.00
- Revenue This Year
- OTTR $1.47
- CPRX $23.85
- Revenue Next Year
- OTTR $0.51
- CPRX $16.76
- P/E Ratio
- OTTR $10.66
- CPRX $20.33
- Revenue Growth
- OTTR 0.41
- CPRX 32.17
- 52 Week Low
- OTTR $71.66
- CPRX $13.12
- 52 Week High
- OTTR $100.84
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- OTTR 52.05
- CPRX 64.31
- Support Level
- OTTR $76.42
- CPRX $22.07
- Resistance Level
- OTTR $80.55
- CPRX $23.14
- Average True Range (ATR)
- OTTR 1.82
- CPRX 1.21
- MACD
- OTTR 0.23
- CPRX 0.13
- Stochastic Oscillator
- OTTR 65.69
- CPRX 96.20
About OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.